Journal issues > Issue Special, January 2025 > Academic session

Academic session

During the academic session of the BSMO 2025 annual meeting, Dr. Matteo Lambertini (University of Genova – IRCCS Ospedale Policlinico San Martino, Italy) talked about the challenges and opportunities in the care of young patients with cancer, particularly young women with breast cancer. Dr. Martine Piccart (Institute Jules Bordet, Belgium) elaborated on the use of surrogate endpoints and the ESMO-MCBS for drug approval.

To read the full artice you have the following options:

Click here to log in. Register for a free subscription*

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top